galantamine
Alzheimer’s disease: pharma’s greatest challenge
April 4, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AD, Alzheimer's, Alzheimer’s, Eisai, Lunt, Pfizer, galantamine, karran, priddy
Like it or not, we are all becoming increasingly prone to a currently incurable and debilitating disease, that places an …
Latest content
The evidence bar impacting UK medical cannabis access
November 6, 2026
Addressing the rheumatic disease diagnostic gap in primary care
November 5, 2026
